ATE465254T1 - Verbindung, zusammensetzung und verfahren zur behandlung von entzündlichen und entzündungs- verwandten erkrankungen - Google Patents

Verbindung, zusammensetzung und verfahren zur behandlung von entzündlichen und entzündungs- verwandten erkrankungen

Info

Publication number: ATE465254T1
Authority: AT; Austria
Prior art keywords: inflammatory; rna; yeast; pharmaceutical composition; compound
Prior art date: 2000-03-24

Application number

AT01926431T

Other languages

English (en)

Inventor

Zenoviy Tkachuk

Original Assignee

Biocell Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-24

Filing date

2001-03-26

Publication date

2010-05-15

2001-03-26 Application filed by Biocell Lab filed Critical Biocell Lab

2010-05-15 Application granted granted Critical

2010-05-15 Publication of ATE465254T1 publication Critical patent/ATE465254T1/de

Links

230000002757 inflammatory effect Effects 0.000 title abstract 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
150000001875 compounds Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
240000004808 Saccharomyces cerevisiae Species 0.000 abstract 3
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 2
208000035475 disorder Diseases 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
229940114079 arachidonic acid Drugs 0.000 abstract 1
235000021342 arachidonic acid Nutrition 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
150000002617 leukotrienes Chemical class 0.000 abstract 1
230000000936 membranestabilizing effect Effects 0.000 abstract 1
230000004060 metabolic process Effects 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
238000010606 normalization Methods 0.000 abstract 1
229920002477 rna polymer Polymers 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Immunology (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01926431T 2000-03-24 2001-03-26 Verbindung, zusammensetzung und verfahren zur behandlung von entzündlichen und entzündungs- verwandten erkrankungen ATE465254T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/534,509 US6737271B1 (en)	2000-03-24	2000-03-24	Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders
PCT/US2001/009590 WO2001073003A1 (en)	2000-03-24	2001-03-26	Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders

Publications (1)

Publication Number	Publication Date
ATE465254T1 true ATE465254T1 (de)	2010-05-15

Family

ID=24130363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01926431T ATE465254T1 (de)	2000-03-24	2001-03-26	Verbindung, zusammensetzung und verfahren zur behandlung von entzündlichen und entzündungs- verwandten erkrankungen

Country Status (9)

Country	Link
US (1)	US6737271B1 (de)
EP (1)	EP1278836B1 (de)
CN (1)	CN1451041B (de)
AT (1)	ATE465254T1 (de)
AU (1)	AU2001252964A1 (de)
DE (1)	DE60141898D1 (de)
EA (1)	EA010182B1 (de)
UA (1)	UA66416C2 (de)
WO (1)	WO2001073003A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7153839B2 (en) *	2000-03-24	2006-12-26	Biocell Laboratories	Method of protecting erythricytes, in particular for improvement of blood cytopenia
DE10309368A1 (de) *	2002-08-06	2004-02-26	Aventis Behring Gmbh Intellectual Property/Legal	Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase
DE10242016A1 (de) *	2002-09-11	2004-03-25	Esplora GmbH c/o TU Darmstadt Institut für Biochemie	Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon
IT1391866B1 (it)	2008-10-30	2012-01-27	Mastelli S R L	Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.
US8420617B2 (en)	2011-03-11	2013-04-16	Biocell Laboratories	Multiantivirus compound, composition and method for treatment of virus diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3615654A (en) *	1968-05-17	1971-10-26	Cpc International Inc	Method of treating microbial cells
US3914450A (en) *	1973-04-09	1975-10-21	Anheuser Busch	Concentrated extract of yeast and processes of making same
EP0786522A2 (de) *	1992-07-17	1997-07-30	Ribozyme Pharmaceuticals, Inc.	Enzymatische RNA-Moleküle zur Behandlung von stenotischen Zuständen
AU7319994A (en)	1993-06-30	1995-01-24	Board Of Regents, The University Of Texas System	Nucleotide preparation and uses thereof in wound healing

2000
- 2000-03-24 US US09/534,509 patent/US6737271B1/en not_active Expired - Fee Related
2001
- 2001-03-26 CN CN018090958A patent/CN1451041B/zh not_active Expired - Fee Related
- 2001-03-26 EP EP01926431A patent/EP1278836B1/de not_active Expired - Lifetime
- 2001-03-26 AU AU2001252964A patent/AU2001252964A1/en not_active Abandoned
- 2001-03-26 EA EA200201015A patent/EA010182B1/ru not_active IP Right Cessation
- 2001-03-26 WO PCT/US2001/009590 patent/WO2001073003A1/en not_active Ceased
- 2001-03-26 AT AT01926431T patent/ATE465254T1/de not_active IP Right Cessation
- 2001-03-26 UA UA2002108298A patent/UA66416C2/uk unknown
- 2001-03-26 DE DE60141898T patent/DE60141898D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CN1451041A (zh)	2003-10-22
EP1278836A1 (de)	2003-01-29
UA66416C2 (en)	2004-05-17
EA010182B1 (ru)	2008-06-30
US6737271B1 (en)	2004-05-18
EP1278836B1 (de)	2010-04-21
EA200201015A1 (ru)	2003-06-26
DE60141898D1 (de)	2010-06-02
EP1278836A4 (de)	2004-07-07
CN1451041B (zh)	2010-06-16
WO2001073003A1 (en)	2001-10-04
AU2001252964A1 (en)	2001-10-08

Similar Documents

Publication	Publication Date	Title
Thappa et al.	1994	Nodulocystic acne: oral gugulipid versus tetracycline
HUP9902103A2 (hu)	1999-10-28	Triarilvegyületek
CA2219115A1 (en)	1996-11-28	N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs
PL360495A1 (en)	2004-09-06	Arylmethylamine derivatives for use as tryptase inhibitors
ATE355374T1 (de)	2006-03-15	Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE477804T1 (de)	2010-09-15	Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
FR2364030A1 (fr)	1978-04-07	Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
ATE406371T1 (de)	2008-09-15	Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung
DE69932939D1 (de)	2006-10-05	Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
GB0012362D0 (en)	2000-07-12	Chemical compounds
BR0308957A (pt)	2005-02-01	Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
NO20006506L (no)	2001-02-21	Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
ATE465254T1 (de)	2010-05-15	Verbindung, zusammensetzung und verfahren zur behandlung von entzündlichen und entzündungs- verwandten erkrankungen
AT509045B1 (de)	2011-06-15	Verbindungen zur behandlung von asthma bronchiale
US11590211B2 (en)	2023-02-28	Systems for treating dermal inflammatory conditions
ATE273682T1 (de)	2004-09-15	Topische formulierungen, die hautpenetrations- mittel enthalten, und ihre verwendung
TNSN99154A1 (fr)	2005-11-10	Compositions pharmaceutiques comprenant des inhibiteurs de nos, leur preparation et leur utilisation
DE60306503D1 (de)	2006-08-10	Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
Sehgal et al.	2002	Antifungal agents: unapproved uses, dosages, or indications
MA53521B1 (fr)	2023-03-31	Nouveaux composés inhibiteurs de la protéase mpro et de la réplication du sars-cov2, leurs formulations et applications
WO2000067732A3 (de)	2001-04-19	Pharmazeutische zusammensetzung enthaltend antimykotikum, polydocanol und salycylsaüre
WO2003066806A3 (en)	2003-12-24	Therapeutic use of aziridino compounds
RU94024641A (ru)	1997-03-20	Способ лечения противовоспалительных процессов
EP0150186A1 (de)	1985-08-07	Zusammensetzung mit verbesserter arzneimittelwirkung und deren verwendung in tiertherapie
MX9605153A (es)	1998-05-31	Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.

Legal Events

Date	Code	Title	Description
2010-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties